Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/07/466   
Active ingredient: L-threo-3,4-dihydroxyphenylserine
Indication: Treatment of orthostatic hypotension in patients with multiple system atrophy
Sponsor: Diamond BioPharm Limited
No 4 East Wing Gemini House, Flex Meadow, Harlow, Essex CM19 5TJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Orphan designation EMEA/OD/025/07 (2007)3818 of 02/08/2007
11/12/2007 Change of address of sponsor
01/04/2009 Transfer of orphan designation EMEA/OD/025/07/T/01 (2009)2488 of 27/03/2009
09/11/2010 Change of address of sponsor EMA/581017/2010
11/03/2011 Transfer of orphan designation EMEA/OD/025/07/T/02 (2011)1684 of 09/03/2011